ACCUIMAGE DIAGNOSTICS CORP
NT 10-Q/A, 1999-08-17
COMPUTER PROGRAMMING SERVICES
Previous: EDISON SCHOOLS INC, S-1/A, 1999-08-17
Next: FOUNDRY NETWORKS INC, S-1/A, 1999-08-17




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                           SEC FILE NUMBER: 000-26555

                            CUSIP NUMBER: 004381109

                                  (Check One):

[ ] Form 10-KSB [ ] Form 20-F [ ] Form 11-K [X] Form 10-QSB [ ] Form N-SAR

         For Period Ended: June 30, 1999

         Nothing in this Form shall be  construed  to imply that the  Commission
has verified any information contained herein.

PART I -- REGISTRANT INFORMATION

                     AccuImage Diagnostics Corp.
                     (Full Name of Registrant)


                     (Former Name if Applicable)

                     400 Oyster Point Blvd., Suite 114
                     (Address of Principal Executive Office (Street and Number)

                     South San Francisco, CA  94080-1917
                     (City, State and Zip Code)



PART II -- RULES 12b-25(b) AND (c)

         If the subject report could not be filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check box if appropriate)

             (a)    The reasons  described in  reasonable  detail in Part III of
                    this form could not be eliminated  without reasonable effort
                    or expense;

             (b)    The subject annual report,  semi-annual  report,  transition
                    report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion
                    thereof,  will be filed on or before the fifteenth  calendar
 [X]                day following the prescribed due date; or the subject
                    quarterly report or transition report on Form 10-Q, or
                    portion thereof,  will be filed on or before  the fifth
                    calendar  day  following  the   prescribed due date; and

             (c)    The accountant's statement or other exhibit required by Rule
                    12b-25 (c) has been attached if applicable.

PART III -- NARRATIVE

         State below in reasonable detail the reasons why the Form 10-KSB, 20-F,
11-K,  10-QSB,  N-SAR, or the transition  report or portion thereof could not be
filed within the prescribed time period.

         The  registrant is unable to file the  quarterly  report on Form 10-QSB
for the quarter  ended June 30, 1999  within the time period  prescribed  by the
Rules and Regulations of the SEC without  unreasonable efforts or expense. It is
unable to gather all of the  information  necessary  to complete  its  unaudited
financial statements for the quarter ended June 30, 1999. The registrant intends
on filing the quarterly report on or before the fifth calendar day following the
prescribed due date.

PART IV -- OTHER INFORMATION

         (1) Name and telephone number of person to contact in regard to this
 notification

         Allen B. Poirson, President and CEO         650          875-0192
                   (Name)                        (Area Code) (Telephone Number)

         (2) Have all other periodic  reports required under section 13 or 15(d)
of the Securities  Exchange Act of 1934 or Section 30 of the Investment  Company
Act of 1940 during the  preceding 12 months or for such shorter  period that the
registrant  was  required to file such  report(s)  been filed?  If answer is no,
identify report(s).

         [X] Yes [  ] No

         (3) Is it  anticipated  that  any  significant  change  in  results  of
operations  from the  corresponding  period  for the last  fiscal  year  will be
reflected by the  earnings  statements  to be included in the subject  report or
portion thereof?

         [  ] Yes [X] No

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results can not be made.

                  AccuImage Diagnostics Corp.
                  (Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date: August 16, 1999                 By: /s/ Allen B. Poirson
                                      -------------------------------
                                              Allen B. Poirson,
                                              President and CEO



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission